We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Revises Final Guidance on Drug Metabolites to Align with ICH Standards
FDA Revises Final Guidance on Drug Metabolites to Align with ICH Standards
The FDA is now directing sponsors to international guideline recommendations for the durations of general toxicity studies that evaluate the direct dosing of drug metabolites.